Manufactures pharmaceutical intermediates and chemicals. Revenue comes from B2B sales and export contracts. Serves pharma manufacturers and research labs. Focuses on quality, compliance, and process efficiency. Operates manufacturing-led B2B model.
Loading chart…
This company hasn't held an earnings call in the last six months, so there's no recent commentary from management. Our deep dives are built on what management actually said, so we haven't prepared one.
Sign in to see dividends, bonuses and splits - free.
Sign in